Harisinghani, Mukesh, MD

Professor

Phone: 617-726-8396
Email: mharisinghani@mgh.harvard.edu
Lab: Harisinghani, Mukesh

Publications

  • Atre ID, Eurboonyanun K, Noda Y, Parakh A, O'Shea A, Lahoud RM, Sell NM, Kunitake H, Harisinghani MG Utility of texture analysis on T2-weighted MR for differentiating tumor deposits from mesorectal nodes in rectal cancer patients, in a retrospective cohort. Abdom Radiol (NY). 2020;:ePub - PMID: 32700214 - DOI: 10.1007/s00261-020-02653-w

  • Atre ID, Eurboonyanun K, O'Shea A, Lahoud RM, Shih A, Kalva S, Harisinghani MG, Hedgire S Predictors of transmural intestinal necrosis in patients presenting with acute mesenteric ischemia on computed tomography. Abdom Radiol (NY). 2020;:ePub - PMID: 32382818 - DOI: 10.1007/s00261-020-02558-8

  • O'Shea A, Kilcoyne A, Hedgire SS, Harisinghani MG Pelvic lymph nodes and pathways of disease spread in male pelvic malignancies. Abdom Radiol (NY). 2020;45(7):2198-2212 - PMID: 31673716 - DOI: 10.1007/s00261-019-02285-9

  • Harisinghani MG, O’Shea A, Weissleder R Advances in clinical MRI technology. Sci Transl Med. 2019;11 (523):eaba2591 - PMID: 31852796 - DOI: 10.1126/scitranslmed.aba2591

  • Kordbacheh H, Baliyan V, Parakh A, Wojtkiewicz GR, Hedgire S, Harisinghani MG Pictorial review on abdominal applications of ferumoxytol in MR imaging. Abdom Radiol (NY). 2019;44(10):3273-3284 - PMID: 31378828 - DOI: 10.1007/s00261-019-02163-4

  • Chulroek T, Kordbacheh H, Wangcharoenrung D, Cattapan K, Heidari P, Harisinghani MG Comparative accuracy of qualitative and quantitative 18F-FDG PET/CT analysis in detection of lymph node metastasis from anal cancer. Abdom Radiol (NY). 2019;44(3):828-835 - PMID: 30694369 - DOI: 10.1007/s00261-019-01907-6

  • Hedgire S, Kilcoyne A, Tonyushkin A, Mao Y, Uyeda JW, Gervais DA, Harisinghani MG Effect of androgen deprivation and radiation therapy on MRI fiber tractography in prostate cancer: Can we assess treatment response on imaging?. Br J Radiol. 2019;:20170170 - PMID: 30209952 - PMCID: PMC6435068 - DOI: 10.1259/bjr.20170170

  • Hedgire S, Krebill C, Wojtkiewicz G, Oliveira I, Ghoshhajra BB, Hoffmann U, Harisinghani MG Ultrasmall superparamagnetic iron oxide nanoparticle uptake as noninvasive marker of aortic wall inflammation on MRI: proof of concept study. Br J Radiol. 2018;:20180461 - PMID: 30160173 - PMCID: PMC6319856 - DOI: 10.1259/bjr.20180461

  • Aganj I, Harisinghani MG, Weissleder R, Fischl B Unsupervised medical image segmentation based on the local center of mass. Sci Rep. 2018;8:13012 - PMID: 30158534 - PMCID: PMC6115387 - DOI: 10.1038/s41598-018-31333-5

  • Hedgire SS, Kudrimoti S, Oliveira IS, Nadkarni N, McDermott S, Hahn PF, Mino-Kenudson M, Harisinghani MG Extranodal lymphomas of abdomen and pelvis: imaging findings and differential diagnosis. Abdom Radiol. 2017;42(4):1096-1112 - PMID: 27866240 - DOI: 10.1007/s00261-016-0964-8

  • Kilcoyne A, Price MC, McDermott S, Harisinghani MG Imaging on nodal staging of prostate cancer. Future Oncol. 2017;13(6):551-565 - PMID: 27785926 - DOI: 10.2217/fon-2016-0216

  • Hassanzadeh E, Glazer DI, Dunne RM, Fennessy FM, Harisinghani MG, Tempany CM Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. Abdom Radiol. 2017;42(1):278-289 - PMID: 27522352 - PMCID: PMC5247306 - DOI: 10.1007/s00261-016-0871-z

  • Kilcoyne A, Harisinghani MG, Mahmood U Prostate Cancer Imaging and Therapy: Potential Role of Nanoparticles. J Nucl Med. 2016;57(Suppl 3):105S-110S - PMID: 27694162 - DOI: 10.2967/jnumed.115.170738

  • Diaz-Gil D, Fintelmann FJ, Molaei S, Elmi A, Hedgire SS, Harisinghani MG Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index. Abdom Radiol. 2016;41(11):2196-2202 - PMID: 27338731 - DOI: 10.1007/s00261-016-0817-5

  • Agarwal S, Grajo JR, Fuentes-Orrego JM, Abtahi SM, Harisinghani MG, Saini S, Hahn PF Distinguishing hemangiomas from metastases on liver MRI performed with gadoxetate disodium: Value of the extended washout sign. Eur J Radiol. 2016;85(3):635-40 - PMID: 26860678 - DOI: 10.1016/j.ejrad.2015.12.028

  • Gaglia JL, Harisinghani M, Aganj I, Wojtkiewicz GR, Hedgire S, Benoist C Mathis D, Weissleder R Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients. Proc Natl Acad Sci U S A. 2015;112(7):2139-44 - PMID: 25650428 - PMCID: PMC4343112 - DOI: 10.1073/pnas.1424993112

  • Iyer VR, Hedgire SS, Hoskote SS, Borczuk D, Harisinghani MG Retrospective cohort study of portacaval lymphadenopathy identified on multidetector CT and implications for follow-up. Abdom Imaging. 2015;40(6):1481-6 - PMID: 25516214 - DOI: 10.1007/s00261-014-0328-1

  • Harisinghani MG The male pelvis. Magn Reson Imaging Clin N Am. 2014;22(2):xi - PMID: 24792681 - DOI: 10.1016/j.mric.2014.02.001

  • Hedgire SS, Mino-Kenudson M, Elmi A, Thayer S, Fernandez-Del Castillo C, Harisinghani MG Enhanced primary tumor delineation in pancreatic adenocarcinoma using ultrasmall super paramagnetic iron oxide nanoparticle-ferumoxytol: an initial experience with histopathologic correlation. Int J Nanomedicine. 2014;9:1891-1896 - PMID: 24790431 - PMCID: PMC4000182 - DOI: 10.2147/IJN.S59788

  • Hedgire SS, Tabatabaei S, McDermott S, Feldman A, Dahl DM, Harisinghani MG Diversion ahead: imaging appearance of urinary diversions and reservoirs. Clin Imaging. 2014;38(4):418-427 - PMID: 24602415 - DOI: 10.1016/j.clinimag.2014.01.017

  • Hedgire SS, Eberhardt SC, Borczuk R, McDermott S, Harisinghani MG Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices. Abdom Imaging. 2014;39(5):1036-51 - PMID: 24566965 - DOI: 10.1007/s00261-014-0097-x

  • Hedgire SS, Elmi A, Kambadakone AR, Yoon S, Blake M, Harisinghani MG MDCT imaging of Alloderm biologic mesh spacers in the abdomen and pelvis - preliminary experience. Clin Imaging. 2014;38(3):279-82 - PMID: 24556330 - DOI: 10.1016/j.clinimag.2013.12.020

  • McDermott S, Thayer SP, Fernandez-Del Castillo C, Mino-Kenudson M, Weissleder R, Harisinghani MG Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle. Transl Oncol. 2013;6(6):670-5 - PMID: 24466369 - PMCID: PMC3890701 - DOI: 10.1593/tlo.13400

  • Podrasky AE, Javitt MC, Glanc P, Dubinsky T, Harisinghani MG, Harris RD, Khati NJ, Mitchell DG, Pandharipande PV, Pannu HK, Shipp TD, Siegel CL, Simpson L, Wall DJ, Wong-You-Cheong JJ, Zelop CM ACR Appropriateness Criteria® Second and Third Trimester Bleeding. Ultrasound Q. 2013;29(4):293-301 - PMID: 24263752 - DOI: 10.1097/RUQ.0000000000000044

  • Mitchell DG, Javitt MC, Glanc P, Bennett GL, Brown DL, Dubinsky T, Harisinghani MG, Harris RD, Horowitz NS, Pandharipande PV, Pannu HK, Podrasky AE, Royal HD, Shipp TD, Siegel CL, Simpson L, Wong-You-Cheong JJ, Zelop CM ACR Appropriateness Criteria Staging and Follow-up of Ovarian Cancer. J Am Coll Radiol. 2013;10(11):822-7 - PMID: 24183551 - DOI: 10.1016/j.jacr.2013.07.017

  • Olumi AF, Kaufman DS, Zietman A, Harisinghani MG, Wu CL Case records of the Massachusetts General Hospital. Case 25-2013. A 71-year-old man with hematuria and a mass in the bladder. N Engl J Med. 2013;369(7):660-7 - PMID: 23944304 - DOI: 10.1056/NEJMcpc1209278

  • Hedgire SS, McDermott S, Borczuk D, Elmi A, Saini S, Harisinghani MG The Spectrum of IgG4-Related Disease in the Abdomen and Pelvis. AJR Am J Roentgenol. 2013;201(1):14-22 - PMID: 23789654 - DOI: 10.2214/AJR.12.9995

  • Gunn AJ, Seethamraju RT, Hedgire S, Elmi A, Daniels GH, Harisinghani MG Imaging Behavior of the Normal Adrenal on Ferumoxytol-Enhanced MRI: Preliminary Findings. AJR Am J Roentgenol. 2013;201(1):117-21 - PMID: 23789664 - DOI: 10.2214/AJR.12.9357

  • Paly JJ, Efstathiou JA, Hedgire SS, Chung PW, O'Malley M, Shah A, Bekelman JE, Harisinghani M, Shipley WU, Zietman AL, Beard C Mapping patterns of nodal metastases in seminoma: Rethinking radiotherapy fields. Radiother Oncol. 2013;106(1):64-8 - PMID: 23321493 - DOI: 10.1016/j.radonc.2012.12.002

  • Preston MA, Harisinghani MG, Mucci L, Witiuk K, Breau RH Diagnostic tests in urology: magnetic resonance imaging (MRI) for the staging of prostate cancer. BJU Int. 2013;111(3):514-7 - PMID: 23320634 - DOI: 10.1111/j.1464-410X.2012.11447.x

  • Hedgire SS, Sainani NI, McDermott S, Hahn PF, Harisinghani MG Mono-belly and beyond: spectrum of imaging manifestations of EBV infection in the abdomen. Clin Imaging. 2013;37(4):711-7 - PMID: 23317894 - DOI: 10.1016/j.clinimag.2012.10.003

  • Rajesh A, Cloud G, Harisinghani MG Improving the quality of manuscript reviews: impact of introducing a structured electronic template to submit reviews. AJR Am J Roentgenol. 2013;200(1):20-3 - PMID: 23255737 - DOI: 10.2214/AJR.11.8299

  • Hedgire SS, Oei TN, McDermott S, Cao K, Patel M Z, Harisinghani MG Multiparametric magnetic resonance imaging of prostate cancer. Indian J Radiol Imaging. 2012;22(3):160-9 - PMID: 23599562 - PMCID: PMC3624737 - DOI: 10.4103/0971-3026.107176

  • Hedgire SS, Elmi A, Nadkarni ND, Cao K, McDermott S, Harisinghani MG Preoperative evaluation of perinephric fat invasion in patients with renal cell carcinoma: correlation with pathological findings. Clin Imaging. 2012;37(1):91-6 - PMID: 23206613 - DOI: 10.1016/j.clinimag.2012.03.005

  • Elmi A, Tabatabaei S, Talab SS, Hedgire SS, Cao K, Harisinghani M Incidental findings at initial imaging workup of patients with prostate cancer: clinical significance and outcomes. AJR Am J Roentgenol. 2012;199(6):1305-11 - PMID: 23169722 - DOI: 10.2214/AJR.11.8417

  • Hedgire SS, Pargaonkar VK, Elmi A, Harisinghani AM, Harisinghani MG Pelvic nodal imaging. Radiol Clin North Am. 2012;50(6):1111-25 - PMID: 23122041 - DOI: 10.1016/j.rcl.2012.08.002

  • Dejesus Allison SO, Javitt MC, Glanc P, Andreotti RF, Bennett GL, Brown DL, Dubinsky T, Harisinghani MG, Harris RD, Mitchell DG, Pandharipande PV, Pannu HK, Podrasky AE, Shipp TD, Siegel CL, Simpson L, Wong-You-Cheong JJ, Zelop CM ACR Appropriateness Criteria® Multiple Gestations. Ultrasound Q. 2012;28(2):149-155 - PMID: 22634795 - DOI: 10.1097/RUQ.0b013e31824bfc06

  • Kaufman DS, Zietman AL, McDougal WS, Dahl DM, Harisinghani MG, Wu CL Case records of the Massachusetts General Hospital. Case 9-2012. A 67-year-old man with a persistently elevated PSA level. N Engl J Med. 2012;366(12):1143-50 - PMID: 22435374 - DOI: 10.1056/NEJMcpc1104320

  • McDermott S, Hedgire SS, Hahn PF, Mueller PR, Harisinghani MG Image-Guided Biopsy of Suspicious Lymph Nodes in Patients with Known Primary Malignancies. J Vasc Interv Radiol. 2012;23(3):371-6 - PMID: 22265244 - DOI: 10.1016/j.jvir.2011.11.028

  • Gold M, Zhang Z, Marques H, Gorelick J, Landrum LM, Mannel RS, Chuang LT, Yu JQ, McCourt CK, Harisinghani M, Sohaib A, Koh D, Raman S, Gee MS, Choi H, Atri M MRI prior to systematic lymphadenectomy in patients with locally advanced cervical cancer. J Clin Oncol. 2011;29(15_suppl):5042 - PMID: 28023697

  • Atri M, Zhang Z, Marques H, Gorelick J, Harisinghani M, Sohaib A, Koh D, Raman S, Gee MS, Choi H, Landrum LM, Mannel RS, Chuang LT, Yu JQ, McCourt CK, Gold M, Utility of preoperative ferumoxtran-10 enhanced MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233. J Clin Oncol. 2011;29(15_suppl):5035 - PMID: 28023716

  • Gee MS, Nimkin K, Hsu M, Israel EJ, Biller JA, Katz AJ, Mino-Kenudson M, Harisinghani MG Prospective Evaluation of MR Enterography as the Primary Imaging Modality for Pediatric Crohn Disease Assessment. AJR Am J Roentgenol. 2011;197(1):224-31 - PMID: 21701034 - PMCID: PMC3711021 - DOI: 10.2214/AJR.10.5970

  • Gee MS, Harisinghani MG MRI in patients with inflammatory bowel disease. J Magn Reson Imaging. 2011;33(3):527-534 - PMID: 21512607 - PMCID: PMC3078716 - DOI: 10.1002/jmri.22504

  • Kaufman DS, Zietman AL, Dahl DM, Harisinghani MG, Wu CL Case records of the Massachusetts General Hospital. Case 5-2011. A 65-year-old man with hematuria after treatment for prostate cancer. N Engl J Med. 2011;364(7):667-75 - PMID: 21323545 - DOI: 10.1056/NEJMcpc1005310

  • Saokar A, Gee MS, Islam T, Mueller PR, Harisinghani MG Appearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10. Clin Imaging. 2010;34(6):448-52 - PMID: 21092874 - DOI: 10.1016/j.clinimag.2009.09.008

  • Gultepe E, Reynoso FJ, Jhaveri A, Kulkarni P, Nagesha D, Ferris C, Harisinghani M, Campbell RB, Sridhar S Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution. Nanomedicine (Lond). 2010;5(8):1173-82 - PMID: 21039195 - DOI: 10.2217/nnm.10.84

  • Islam T, Harisinghani MG Prostate cancer imaging: what the next decade holds. Expert Rev Med Devices. 2010;7(5):577-9 - PMID: 20822379 - DOI: 10.1586/erd.10.43

  • Saokar A, Islam T, Jantsch M, Saksena MA, Hahn PF, Harisinghani MG Detection of lymph nodes in pelvic malignancies with computed tomography and magnetic resonance imaging. Clin Imaging. 2010;34(5):361-6 - PMID: 20813300 - DOI: 10.1016/j.clinimag.2009.07.004

  • Cronin CG, Harisinghani MG, Catalano O, Blake MA Multitechnique imaging findings of prolene plug hernia repair. AJR Am J Roentgenol. 2010;195(3):701-6 - PMID: 20729449 - DOI: 10.2214/AJR.09.4142

  • Pandharipande PV, Gervais DA, Hartman RI, Harisinghani MG, Feldman AS, Mueller PR, Gazelle GS Renal Mass Biopsy to Guide Treatment Decisions for Small Incidental Renal Tumors: A Cost-effectiveness Analysis. Radiology. 2010;256(3):836-46 - PMID: 20720070 - PMCID: PMC2923731 - DOI: 10.1148/radiol.10092013

  • Sanghvi D, Harisinghani MG Modalities in modern radiology: A synopsis. J Postgrad Med. 2010;56(2):85-7 - PMID: 20622386 - DOI: 10.4103/0022-3859.65282

  • de la Rosette J, Ahmed H, Barentsz J, Johansen TB, Brausi M, Emberton M, Frauscher F, Greene D, Harisinghani M, Haustermans K, Heidenreich A, Kovacs G, Mason M, Montironi R, Mouraviev V, de Reijke T, Taneja S, Thuroff S, Tombal B, Trachtenberg J, Wijkstra H, Polascik T Focal therapy in prostate cancer-report from a consensus panel. J Endourol. 2010;24(5):775-80 - PMID: 20477543 - DOI: 10.1089/end.2009.0596

  • Uppot RN, Harisinghani MG, Gervais DA Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol. 2010;194(6):1443-9 - PMID: 20489082 - DOI: 10.2214/AJR.10.4427

  • Eisner BH, Kurtz MP, Harisinghani MG Evolving Role of Magnetic Resonance Imaging in Renal Cancer Imaging. J Endourol. 2010;24(5):707-11 - PMID: 20433369 - DOI: 10.1089/end.2009.0507

  • Iyer VR, Hahn PF, Blaszkowsky LS, Thayer SP, Halpern EF, Harisinghani MG Added Value of Selected Images Embedded Into Radiology Reports to Referring Clinicians. J Am Coll Radiol. 2010;7(3):205-210 - PMID: 20193926 - PMCID: PMC3086392 - DOI: 10.1016/j.jacr.2009.10.014

  • Ventura E, Islam T, Gee MS, Mahmood U, Braschi M, Harisinghani MG Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT. Clin Imaging. 2010;34(1):20-28 - PMID: 20122515 - DOI: 10.1016/j.clinimag.2009.03.012

  • Kaufman DS, McDougal WS, Harisinghani MG, Wu CL Case records of the Massachusetts General Hospital. Case 30-2009. A 77-year-old man with recurrent transitional-cell carcinoma of the ureter. N Engl J Med. 2009;361(13):1292-9 - PMID: 19776411 - DOI: 10.1056/NEJMcpc0900642

  • Baier ND, Hahn PF, Gervais DA, Samir A, Halpern EF, Mueller PR, Harisinghani MG Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol. 2009;193(4):1175-9 - PMID: 19770344 - DOI: 10.2214/AJR.08.1840

  • Pandharipande PV, Mora JT, Uppot RN, Goehler A, Braschi M, Halpern EF, Gazelle GS, Harisinghani MG Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model. AJR Am J Roentgenol. 2009;193(3):W230-7 - PMID: 19696264 - DOI: 10.2214/AJR.08.2175

  • Ross RW, Zietman AL, Xie W, Coen JJ, Dahl DM, Shipley WU, Kaufman DS, Islam T, Guimaraes AR, Weissleder R, Harisinghani M Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy. Clin Imaging. 2009;33(4):301-5 - PMID: 19559353 - DOI: 10.1016/j.clinimag.2009.01.013

  • Harisinghani MG Nanoparticle enhanced imaging. Cancer Biomark. 2009;5(2):59 - PMID: 19414921 - DOI: 10.3233/CBM-2009-0614

  • Islam T, Harisinghani MG Overview of nanoparticle use in cancer imaging. Cancer Biomark. 2009;5:61-7 - PMID: 19414922 - DOI: 10.3233/CBM-2009-0578

  • Gee MS, Harisinghani MG, Tabatabaei S Molecular imaging in urologic surgery. Urol Clin N Am. 2009;36(2):125-32 - PMID: 19406314 - DOI: 10.1016/j.ucl.2009.02.007

  • Pandharipande PV, Harisinghani MG, Ozanne EM, Specht MC, Hur C, Lee JM, Gazelle GS Staging MR Lymphangiography of the Axilla for Early Breast Cancer: Cost-Effectiveness Analysis. AJR Am J Roentgenol. 2008;191:1308-19 - PMID: 18941062 - DOI: 10.2214/AJR.07.3861

  • Roedl JB, Blake MA, Holalkere NS, Mueller PR, Colen RR, Harisinghani MG Lymph node staging in esophageal adenocarcinoma with PET-CT based on a visual analysis and based on metabolic parameters. Abdom Imaging. 2008;34(5):610-7 - PMID: 18830663 - DOI: 10.1007/s00261-008-9447-x

  • Roedl JB, Harisinghani MG, Colen RR, Fischman AJ, Blake MA, Mathisen DJ, Mueller PR Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg. 2008;86:1131-8 - PMID: 18805147 - DOI: 10.1016/j.athoracsur.2008.05.019

  • Harisinghani M Nanoparticle-enhanced MRI: are we there yet?. Lancet Oncol. 2008;9(9):814-815 - PMID: 18760237 - DOI: 10.1016/S1470-2045(08)70215-8

  • Li CS, Harisinghani MG, Lin WC, Braschi M, Hahn PF, Mueller PR Enhancement Characteristics of Ultrasmall Superparamagnetic Iron Oxide Particle Within the Prostate Gland in Patients With Primary Prostate Cancer. J Comput Assist Tomogr. 2008;32:523-528 - PMID: 18664836 - DOI: 10.1097/RCT.0b013e318136e194

  • Feldman AS, McDougal WS, Harisinghani MG The potential of nanoparticle-enhanced imaging. Urol Oncol. 2008;26(1):65-73 - PMID: 18190834 - DOI: 10.1016/j.urolonc.2007.03.016

  • Guimaraes AR, Tabatabei S, Dahl D, McDougal WS, Weissleder R, Harisinghani MG Pilot Study Evaluating Use of Lymphotrophic Nanoparticle-Enhanced Magnetic Resonance Imaging for Assessing Lymph Nodes in Renal Cell Cancer. Urology. 2008;71(4):708-12 - PMID: 18295316 - DOI: 10.1016/j.urology.2007.11.096

  • Harisinghani M, Ross R, Guimaraes A, Weissleder R Utility of a New Bolus-Injectable Nanoparticle for Clinical Cancer Staging. Neoplasia. 2007;(9)12:1160-1165 - PMID: 18084623 - PMCID: PMC2134912 - DOI: 10.1593/neo.07940

  • Saksena M, Harisinghani M, Hahn P, Kim J, Saokar A, King B, Weissleder R Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers. AJR Am J Roentgenol. 2006;187(6):W582-8 - PMID: 17114509 - DOI: 10.2214/AJR.05.0873

  • Ross R, Harisinghani M New clinical imaging modalities in prostate cancer. Hematol Oncol Clin N. 2006;20(4):811-30 - PMID: 16861116 - DOI: 10.1016/j.hoc.2006.03.009

  • Ross R, Harisinghani M Prostate cancer imaging-what the urologic oncologist needs to know. Radiol Clin North Am. 2006;44(5):711-22 - PMID: 17030222 - DOI: 10.1016/j.rcl.2006.07.002

  • Saokar A, Braschi M, Harisinghani M Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging. Abdom Imaging. 2006;31(6):660-7 - PMID: 16680506 - DOI: 10.1007/s00261-006-9006-2

  • Saksena MA, Saokar A, Harisinghani MG Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol. 2006;58(3):367-74 - PMID: 16472955 - DOI: 10.1016/j.ejrad.2005.12.041

  • Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi MT, Weissleder R Ferumoxtran-10-Enhanced MR Lymphangiography: Does Contrast-Enhanced Imaging Alone Suffice for Accurate Lymph Node Characterization?. AJR Am J Roentgenol. 2006;186(1):144-8 - PMID: 16357394 - DOI: 10.2214/AJR.04.1287

  • Harisinghani MG, Saksena M, Ross RW, Tabatabaei S, Dahl D, McDougal S, Weissleder R A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. Urology. 2005;66(5):1066-71 - PMID: 16286125 - DOI: 10.1016/j.urology.2005.05.049

  • Shih HA, Harisinghani M, Zietman AL, Wolfgang JA, Saksena M, Weissleder R. Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys. 2005;63(4):1262-9 - PMID: 16253781 - DOI: 10.1016/j.ijrobp.2005.07.952

  • Harisinghani MG, Weissleder R Sensitive, noninvasive detection of lymph node metastases. PLoS Med. 2004;1(3):e66 - PMID: 15630471 - PMCID: PMC539052 - DOI: 10.1371/journal.pmed.0010066

  • Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491-9 - PMID: 12815134 - DOI: 10.1056/NEJMoa022749

  • Harisinghani MG, Barentsz JO, Hahn PF, Deserno W, de la Rosette J, Saini S, Marten K, Weissleder R MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer. Acad Radiol. 2002;9 Suppl 2:S312-3 - PMID: 12188258 - DOI: 10.1016/s1076-6332(03)80213-1

  • Harisinghani MG, Jhaveri KS, Weissleder R, Schima W, Saini S, Hahn PF, Mueller PR MRI contrast agents for evaluating focal hepatic lesions. Clin Radiol. 2001;56:714-25 - PMID: 11585393 - DOI: 10.1053/crad.2001.0764

  • Harisinghani MG, Saini S, Weissleder R, Rubin D, deLange E, Harms S, Weinreb J, Small W, Sukerkar A, Brown JJ, Zelch J, Lucas M, Morris M, Hahn PF Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations. J Comput Assist Tomogr. 2001;25:770-6 - PMID: 11584239 - DOI: 10.1097/00004728-200109000-00017

  • Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, Mueller PR MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol. 1999;172:1347-51 - PMID: 10227514 - DOI: 10.2214/ajr.172.5.10227514

  • Schima W, Saini S, Petersein J, Weissleder R, Harisinghani M, Mayo-Smith W, Hahn PF MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses. J Magn Reson Imaging. 1999;10:80-3 - PMID: 10398981 - DOI: 10.1002/(sici)1522-2586(199907)10:1<80::aid-jmri11>3.0.co;2-s

  • Harisinghani MG, Saini S, Hahn PF, Weissleder R, Mueller PR MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex). Acad Radiol. 1998;5 Suppl 1:S167-9, discussion S183-4 - PMID: 9561072 - DOI: 10.1016/s1076-6332(98)80095-0

  • Harisinghani MG, Saini S, Weissleder R, Halpern EF, Schima W, Rubin DL, Stillman AE, Sica GT, Small WC, Hahn PF Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227. Radiology. 1997;202(3):687-91 - PMID: 9051017 - DOI: 10.1148/radiology.202.3.9051017